Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Cardiff

Showing results (161-170 of 182) with videos related to

Pageof 19
Sort By:
The Journal of Biological Chemistry|May 23, 2013
An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1RMasaaki Fujita, Katsuaki Ieguchi, Dora M Cedano-Prieto, et al.
Breast Cancer Research : BCR|July 7, 2025
Overexpression of TSG101 causes the development of adenosquamous mammary carcinomaRayane Dennaoui, Patrick D Rädler, Madison N Wicker, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2013
Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancersRobert D Cardiff, Neil E Hubbard, Jesse A Engelberg, et al.
NPJ Breast Cancer|March 25, 2022
Intratumoral in vivo staging of breast cancer by multi-tracer PET and advanced analysisJennifer Griessinger, Julian Schwab, Qian Chen, et al.
Molecular Pharmaceutics|October 8, 2010
Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicityAzadeh Kheirolomoom, Lisa M Mahakian, Chun-Yen Lai, et al.
Plos One|June 16, 2015
Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-DependentJane Q Chen, Hidetoshi Mori, Robert D Cardiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Ductal carcinoma in situ: state of the science and roadmap to advance the fieldHenry M Kuerer, Constance T Albarracin, Wei T Yang, et al.
Cancer Research|November 4, 2005
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout miceLouise R Howe, Sung-Hee Chang, Kelly C Tolle, et al.
Human Pathology|September 28, 2015
"Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoringJesse A Engelberg, Hanna Retallack, Ronald Balassanian, et al.
Oncotarget|May 6, 2015
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesisMathew C Casimiro, Gabriele Di Sante, Marco Crosariol, et al.
Pageof 19

Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
The Journal of Biological Chemistry|May 23, 2013
An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1RMasaaki Fujita, Katsuaki Ieguchi, Dora M Cedano-Prieto, et al.
Breast Cancer Research : BCR|July 7, 2025
Overexpression of TSG101 causes the development of adenosquamous mammary carcinomaRayane Dennaoui, Patrick D Rädler, Madison N Wicker, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2013
Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancersRobert D Cardiff, Neil E Hubbard, Jesse A Engelberg, et al.
NPJ Breast Cancer|March 25, 2022
Intratumoral in vivo staging of breast cancer by multi-tracer PET and advanced analysisJennifer Griessinger, Julian Schwab, Qian Chen, et al.
Molecular Pharmaceutics|October 8, 2010
Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicityAzadeh Kheirolomoom, Lisa M Mahakian, Chun-Yen Lai, et al.
Plos One|June 16, 2015
Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-DependentJane Q Chen, Hidetoshi Mori, Robert D Cardiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Ductal carcinoma in situ: state of the science and roadmap to advance the fieldHenry M Kuerer, Constance T Albarracin, Wei T Yang, et al.
Cancer Research|November 4, 2005
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout miceLouise R Howe, Sung-Hee Chang, Kelly C Tolle, et al.
Human Pathology|September 28, 2015
"Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoringJesse A Engelberg, Hanna Retallack, Ronald Balassanian, et al.
Oncotarget|May 6, 2015
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesisMathew C Casimiro, Gabriele Di Sante, Marco Crosariol, et al.
Pageof 19